Abzena
↗Cambridge, United Kingdom
Abzena is a leading global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) that provides fully integrated solutions for the discovery, development, and manufacture of complex biologics and bioconjugates. The company specializes in Antibody-Drug Conjugates (ADCs), monoclonal antibodies (mAbs), and other recombinant proteins, supporting clients from early-stage discovery through to commercial launch.
Headquartered in the UK with significant operations in the US, Abzena leverages proprietary technologies such as ThioBridge® for site-specific conjugation and AbZelectPRO™ for cell line development. The company is known for its 'developability' approach, which integrates manufacturing considerations into the early discovery phase to de-risk drug programs and accelerate timelines to the clinic.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$25M-$100M
Founded:2001
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$122M
Investors:Welsh, Carson, Anderson & Stowe (WCAS), Biospring Partners, Oxeon Partners, Mercia, Invesco Perpetual
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Service Provider)
Modalities:mAb, ADC, AOC, RDC, Fusion proteins, Vaccines
Active Trials:40
Trial Phases:Phase 1: 25 | Phase 2: 10 | Phase 3: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Welsh, Carson, Anderson & Stowe
Acquired By:Welsh, Carson, Anderson & Stowe (2018-10-01)
Subsidiaries:Antitope, PolyTherics, PacificGMP
Key Partnerships:Mabqi (Strategic discovery partnership), Orion Corporation (Licensing agreement), Sartorius Stedim (Technology partner)
COMPETITION
Position:Leader
Competitors:Lonza, Catalent, WuXi Biologics, Samsung Biologics, Celonic, Anthem Biosciences
LEADERSHIP
Key Executives:
Matthew Stober - CEO
Campbell Bunce - CSO
Scientific Founders:Sunil Shaunak
Board Members:Jonathan Goldman, Michelle Dipp
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Abzena and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Abzena. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.